• Je něco špatně v tomto záznamu ?

Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma

M. John, M. Helal, J. Duell, G. Mattavelli, E. Stanojkovska, N. Afrin, AM. Leipold, MJ. Steinhardt, X. Zhou, D. Žihala, A. Anilkumar Sithara, J. Mersi, JM. Waldschmidt, C. Riedhammer, SK. Kadel, M. Truger, RA. Werner, C. Haferlach, H. Einsele, K....

. 2024 ; 144 (20) : 2121-2135. [pub] 20241114

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003460

Extramedullary disease (EMD) is a high-risk feature of multiple myeloma (MM) and remains a poor prognostic factor, even in the era of novel immunotherapies. Here, we applied spatial transcriptomics (RNA tomography for spatially resolved transcriptomics [tomo-seq] [n = 2] and 10x Visium [n = 12]) and single-cell RNA sequencing (n = 3) to a set of 14 EMD biopsies to dissect the 3-dimensional architecture of tumor cells and their microenvironment. Overall, infiltrating immune and stromal cells showed both intrapatient and interpatient variations, with no uniform distribution over the lesion. We observed substantial heterogeneity at the copy number level within plasma cells, including the emergence of new subclones in circumscribed areas of the tumor, which is consistent with genomic instability. We further identified the spatial expression differences between GPRC5D and TNFRSF17, 2 important antigens for bispecific antibody therapy. EMD masses were infiltrated by various immune cells, including T cells. Notably, exhausted TIM3+/PD-1+ T cells diffusely colocalized with MM cells, whereas functional and activated CD8+ T cells showed a focal infiltration pattern along with M1 macrophages in tumor-free regions. This segregation of fit and exhausted T cells was resolved in the case of response to T-cell-engaging bispecific antibodies. MM and microenvironment cells were embedded in a complex network that influenced immune activation and angiogenesis, and oxidative phosphorylation represented the major metabolic program within EMD lesions. In summary, spatial transcriptomics has revealed a multicellular ecosystem in EMD with checkpoint inhibition and dual targeting as potential new therapeutic avenues.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003460
003      
CZ-PrNML
005      
20250206104346.0
007      
ta
008      
250121s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1182/blood.2024024590 $2 doi
035    __
$a (PubMed)39172759
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a John, Mara $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany
245    10
$a Spatial transcriptomics reveals profound subclonal heterogeneity and T-cell dysfunction in extramedullary myeloma / $c M. John, M. Helal, J. Duell, G. Mattavelli, E. Stanojkovska, N. Afrin, AM. Leipold, MJ. Steinhardt, X. Zhou, D. Žihala, A. Anilkumar Sithara, J. Mersi, JM. Waldschmidt, C. Riedhammer, SK. Kadel, M. Truger, RA. Werner, C. Haferlach, H. Einsele, K. Kretzschmar, T. Jelínek, A. Rosenwald, KM. Kortüm, A. Riedel, L. Rasche
520    9_
$a Extramedullary disease (EMD) is a high-risk feature of multiple myeloma (MM) and remains a poor prognostic factor, even in the era of novel immunotherapies. Here, we applied spatial transcriptomics (RNA tomography for spatially resolved transcriptomics [tomo-seq] [n = 2] and 10x Visium [n = 12]) and single-cell RNA sequencing (n = 3) to a set of 14 EMD biopsies to dissect the 3-dimensional architecture of tumor cells and their microenvironment. Overall, infiltrating immune and stromal cells showed both intrapatient and interpatient variations, with no uniform distribution over the lesion. We observed substantial heterogeneity at the copy number level within plasma cells, including the emergence of new subclones in circumscribed areas of the tumor, which is consistent with genomic instability. We further identified the spatial expression differences between GPRC5D and TNFRSF17, 2 important antigens for bispecific antibody therapy. EMD masses were infiltrated by various immune cells, including T cells. Notably, exhausted TIM3+/PD-1+ T cells diffusely colocalized with MM cells, whereas functional and activated CD8+ T cells showed a focal infiltration pattern along with M1 macrophages in tumor-free regions. This segregation of fit and exhausted T cells was resolved in the case of response to T-cell-engaging bispecific antibodies. MM and microenvironment cells were embedded in a complex network that influenced immune activation and angiogenesis, and oxidative phosphorylation represented the major metabolic program within EMD lesions. In summary, spatial transcriptomics has revealed a multicellular ecosystem in EMD with checkpoint inhibition and dual targeting as potential new therapeutic avenues.
650    _2
$a lidé $7 D006801
650    12
$a mnohočetný myelom $x genetika $x patologie $x imunologie $7 D009101
650    12
$a nádorové mikroprostředí $x imunologie $x genetika $7 D059016
650    12
$a transkriptom $7 D059467
650    _2
$a T-lymfocyty $x imunologie $x patologie $x metabolismus $7 D013601
650    _2
$a stanovení celkové genové exprese $7 D020869
655    _2
$a časopisecké články $7 D016428
700    1_
$a Helal, Moutaz $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany $1 https://orcid.org/0000000295611669
700    1_
$a Duell, Johannes $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Mattavelli, Greta $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany $1 https://orcid.org/0009000522087017
700    1_
$a Stanojkovska, Emilia $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Afrin, Nazia $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Leipold, Alexander M $u Helmholtz Institute for RNA-based Infection Research, Helmholtz-Center for Infection Research, Würzburg, Germany $1 https://orcid.org/0000000294713276
700    1_
$a Steinhardt, Maximilian J $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Zhou, Xiang $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Žihala, David $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Anilkumar Sithara, Anjana $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Mersi, Julia $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Waldschmidt, Johannes M $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Riedhammer, Christine $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Kadel, Sofie-Katrin $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Truger, Marietta $u Munich Leukemia Laboratory, Munich, Germany
700    1_
$a Werner, Rudolf A $u Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany $u Department of Nuclear Medicine, Clinic for Radiology and Nuclear Medicine, University Hospital, Goethe University Frankfurt, Frankfurt, Germany
700    1_
$a Haferlach, Claudia $u Munich Leukemia Laboratory, Munich, Germany
700    1_
$a Einsele, Hermann $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Kretzschmar, Kai $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany $1 https://orcid.org/0000000247456684
700    1_
$a Jelínek, Tomáš $u Department of Hematooncology, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic $u Department of Hematooncology, University Hospital Ostrava, Ostrava, Czech Republic $1 https://orcid.org/0000000254679253
700    1_
$a Rosenwald, Andreas $u Institute of Pathology, University of Würzburg, Würzburg, Germany
700    1_
$a Kortüm, K Martin $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany $1 https://orcid.org/0000000270110286
700    1_
$a Riedel, Angela $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany
700    1_
$a Rasche, Leo $u Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany $u Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany $1 https://orcid.org/0000000295369649
773    0_
$w MED00000807 $t Blood $x 1528-0020 $g Roč. 144, č. 20 (2024), s. 2121-2135
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39172759 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104342 $b ABA008
999    __
$a ok $b bmc $g 2263311 $s 1239467
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 144 $c 20 $d 2121-2135 $e 20241114 $i 1528-0020 $m Blood $n Blood $x MED00000807
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Možnosti archivace